Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2007 1
2009 1
2010 1
2011 4
2012 1
2013 1
2014 3
2015 3
2021 3
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.
Repka MX, Weise KK, Chandler DL, Wu R, Melia BM, Manny RE, Kehler LAF, Jordan CO, Raghuram A, Summers AI, Lee KA, Petersen DB, Erzurum SA, Pang Y, Lenhart PD, Ticho BH, Beck RW, Kraker RT, Holmes JM, Cotter SA; Pediatric Eye Disease Investigator Group. Repka MX, et al. JAMA Ophthalmol. 2023 Aug 1;141(8):756-765. doi: 10.1001/jamaophthalmol.2023.2855. JAMA Ophthalmol. 2023. PMID: 37440213
Periocular hemangiomas and lymphangiomas.
Reem RE, Golden RP. Reem RE, et al. Among authors: golden rp. Pediatr Clin North Am. 2014 Jun;61(3):541-53. doi: 10.1016/j.pcl.2014.03.007. Epub 2014 Mar 28. Pediatr Clin North Am. 2014. PMID: 24852151 Review.
Phosphonofluoresceins: Synthesis, Spectroscopy, and Applications.
Turnbull JL, Benlian BR, Golden RP, Miller EW. Turnbull JL, et al. Among authors: golden rp. J Am Chem Soc. 2021 Apr 28;143(16):6194-6201. doi: 10.1021/jacs.1c01139. Epub 2021 Apr 2. J Am Chem Soc. 2021. PMID: 33797899 Free PMC article.
Mild and scalable synthesis of phosphonorhodamines.
Turnbull JL, Golden RP, Benlian BR, Henn KM, Lipman SM, Miller EW. Turnbull JL, et al. Among authors: golden rp. Chem Sci. 2023 Oct 5;14(41):11365-11373. doi: 10.1039/d3sc02590j. eCollection 2023 Oct 25. Chem Sci. 2023. PMID: 37886078 Free PMC article.
The Pediatric Optic Neuritis Prospective Outcomes Study: Two-Year Results.
Pineles SL, Henderson RJ, Repka MX, Heidary G, Liu GT, Waldman AT, Borchert MS, Khanna S, Graves JS, Collinge JE, Conley JA, Davis PL, Kraker RT, Cotter SA, Holmes JM; Pediatric Eye Disease Investigator Group. Pineles SL, et al. Ophthalmology. 2022 Aug;129(8):856-864. doi: 10.1016/j.ophtha.2022.03.021. Epub 2022 Mar 29. Ophthalmology. 2022. PMID: 35364222 Free PMC article.
Central corneal thickness in children.
Pediatric Eye Disease Investigator Group; Bradfield YS, Melia BM, Repka MX, Kaminski BM, Davitt BV, Johnson DA, Kraker RT, Manny RE, Matta NS, Weise KK, Schloff S. Pediatric Eye Disease Investigator Group, et al. Arch Ophthalmol. 2011 Sep;129(9):1132-8. doi: 10.1001/archophthalmol.2011.225. Arch Ophthalmol. 2011. PMID: 21911662 Free PMC article.
Neurodevelopmental outcome of preterm infants enrolled in myo-inositol randomized controlled trial.
Adams-Chapman I, Watterberg KL, Nolen TL, Hirsch S, Cole CA, Cotten CM, Oh W, Poindexter BB, Zaterka-Baxter KM, Das A, Lacy CB, Scorsone AM, Duncan AF, DeMauro SB, Goldstein RF, Colaizy TT, Wilson-Costello DE, Purdy IB, Hintz SR, Heyne RJ, Myers GJ, Fuller J, Merhar S, Harmon HM, Peralta-Carcelen M, Kilbride HW, Maitre NL, Vohr BR, Natarajan G, Mintz-Hittner H, Quinn GE, Wallace DK, Olson RJ, Orge FH, Tsui I, Gaynon M, Hutchinson AK, He YG, Winter TW, Yang MB, Haider KM, Cogen MS, Hug D, Bremer DL, Donahue JP, Lucas WR, Phelps DL, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Adams-Chapman I, et al. J Perinatol. 2021 Aug;41(8):2072-2087. doi: 10.1038/s41372-021-01018-5. Epub 2021 Mar 23. J Perinatol. 2021. PMID: 33758387 Free PMC article. Clinical Trial.
Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes.
Freedman SF, Hercinovic A, Wallace DK, Kraker RT, Li Z, Bhatt AR, Boente CS, Crouch ER, Hubbard GB, Rogers DL, VanderVeen D, Yang MB, Cheung NL, Cotter SA, Holmes JM; Pediatric Eye Disease Investigator Group. Freedman SF, et al. Ophthalmology. 2022 Oct;129(10):1120-1128. doi: 10.1016/j.ophtha.2022.05.019. Epub 2022 Jun 1. Ophthalmology. 2022. PMID: 35660415 Free PMC article.
Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants.
Writing Committee for the Pediatric Eye Disease Investigator Group; Hartnett ME, Wallace DK, Dean TW, Li Z, Boente CS, Dosunmu EO, Freedman SF, Golden RP, Kong L, Prakalapakorn SG, Repka MX, Smith LE, Wang H, Kraker RT, Cotter SA, Holmes JM. Writing Committee for the Pediatric Eye Disease Investigator Group, et al. Among authors: golden rp. JAMA Ophthalmol. 2022 Apr 1;140(4):337-344. doi: 10.1001/jamaophthalmol.2022.0030. JAMA Ophthalmol. 2022. PMID: 35446359 Free PMC article.
26 results